We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Guidance for Trials During COVID-19 With Three New Topics
FDA Updates Guidance for Trials During COVID-19 With Three New Topics
The FDA yesterday updated its March guidance on managing clinical trials during COVID-19 by saying that sites can conduct patient visits via video conference with some advance planning.